These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2978123)

  • 41. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
    Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
    Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnosis, incidence and clinical significance of premature LH rise/peak in patients of an in vitro fertilization and gamete transfer program].
    Urbancsek J; Rabe T; Grunwald K; Runnebaum B
    Geburtshilfe Frauenheilkd; 1990 Jun; 50(6):454-62. PubMed ID: 2376305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?
    Kol S; Humaidan P
    Reprod Biomed Online; 2010 Nov; 21(5):590-2. PubMed ID: 20851052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of the refractory period to gonadotropin therapy in IVF-ET cycles post longacting gonadotropin-releasing hormone (GNRH) analogue.
    Ashkenazi J; Goldman GA; Dicker D; Feldberg D; Shelef M; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1991 Mar; 39(1):37-40. PubMed ID: 1827627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of oestradiol values in IVF-ET under a combined GnRH analogue--desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies.
    Mettler L; Tavmergen EN
    Hum Reprod; 1989 Nov; 4(8 Suppl):59-64. PubMed ID: 2533218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of a long-acting and short-acting GnRH analog in combination with gonadotropins in in vitro fertilization under various indications].
    Schmutzler RK; Reichert C; Diedrich K; Wildt L; Diedrich C; van der Ven H; Al-Hasani S; Krebs D
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():85-90. PubMed ID: 2522902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The spontaneous LH surge in ovarian hyperstimulation for assisted reproductive technology.
    Hoshiai H; Ishikawa M; Ohi T; Fukaya T
    Ann Acad Med Singap; 1992 Jul; 21(4):476-9. PubMed ID: 1309115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates.
    Casper RF; Erskine HJ; Armstrong DT; Brown SE; Daniel SA; Graves GR; Yuzpe AA
    Fertil Steril; 1988 Apr; 49(4):644-8. PubMed ID: 3127247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF.
    Janssens RM; Vermeiden JP; Lambalk CB; Schats R; Schoemaker J
    Hum Reprod; 1998 Sep; 13(9):2386-91. PubMed ID: 9806254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization.
    Imoedemhe DA; Sigue AB; Pacpaco EL; Olazo AB
    Fertil Steril; 1991 Feb; 55(2):328-32. PubMed ID: 1899396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Programmed stimulation for in vitro fertilization].
    Imthurn B; Macas E; Hotz E; Keller PJ
    Geburtshilfe Frauenheilkd; 1992 Jan; 52(1):27-31. PubMed ID: 1532154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ovarian stimulation with pure FSH in an in vitro fertilization program].
    Diedrich K; Diedrich C; Wildt L; van der Ven H; Al-Hasani S; Werner A; Krebs D
    Geburtshilfe Frauenheilkd; 1987 Sep; 47(9):612-8. PubMed ID: 3119421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
    Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
    Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of IVF and ET 1992-95 at the Gynecological-Obstetrical Clinic in Olomouc--comparison of stimulation protocols].
    Oborná I; Talas M; Dostál J; Chrastinová L; Kudela M
    Ceska Gynekol; 1996 Dec; 61(6):349-51. PubMed ID: 8998585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Influence of exogenous supplementation with luteinizing hormone during controlled ovarian hyperstimulation on the results of IVF cycle].
    Toporcerová S; Hredzák R; Ostró A; Zdilová V; Potoceková D
    Ceska Gynekol; 2005 May; 70(3):187-91. PubMed ID: 16047921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization.
    Bentick B; Shaw RW; Iffland CA; Burford G; Bernard A
    Fertil Steril; 1988 Jul; 50(1):79-84. PubMed ID: 3133251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
    Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
    J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [GnRH agonist treatment for in vitro fertilization in hyperandrogenemia].
    Schmutzler RK; Germer U; Diedrich K; Krebs D
    Geburtshilfe Frauenheilkd; 1994 Sep; 54(9):510-4. PubMed ID: 7988854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.
    Firmin C; Antoine JM; Millot F; Alvarez S; Debray M; Tibi C; Cornet D; Salat-Baroux J; Laruelle P
    Hum Reprod; 1991 May; 6(5):653-8. PubMed ID: 1834692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
    Lindner C; Braendle W; Köhler S; Bettendorf G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.